Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 2
2008 1
2009 2
2010 4
2011 6
2012 5
2013 3
2014 4
2015 4
2016 3
2018 5
2019 4
2020 2
2021 3
2022 6
2023 3
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

47 results

Results by year

Filters applied: . Clear all
Page 1
Showing results for peragine n
Search for Pélagie N instead (2 results)
The antileukemic potential of natural killer cells.
Torelli GF, Peragine N, Mariglia P, Foà R. Torelli GF, et al. Among authors: peragine n. Immunotherapy. 2016;8(4):425-34. doi: 10.2217/imt-2015-0009. Immunotherapy. 2016. PMID: 26973124 Review.
Sialylation regulates migration in chronic lymphocytic leukemia.
Natoni A, Cerreto M, De Propris MS, Del Giudice I, Soscia R, Peragine N, Intoppa S, Milani ML, Guarini A, Foà R. Natoni A, et al. Among authors: peragine n. Haematologica. 2023 Jul 1;108(7):1851-1860. doi: 10.3324/haematol.2022.281999. Haematologica. 2023. PMID: 36779594 Free PMC article.
Hairy cell leukaemia with low CD103 expression: A rare but important diagnostic pitfall.
De Propris MS, Musiu P, Intoppa S, Nardacci MG, Pucciarini A, Santi A, Peragine N, Canichella M, De Luca ML, D'Elia GM, Del Giudice I, Pulsoni A, Falini B, Guarini A, Martelli M, Tiacci E, Foà R. De Propris MS, et al. Among authors: peragine n. Br J Haematol. 2022 Jul;198(2):e28-e31. doi: 10.1111/bjh.18224. Epub 2022 May 2. Br J Haematol. 2022. PMID: 35499213 No abstract available.
Long-Term Host Immune Modulation Following Tisagenlecleucel Administration in Patients with Diffuse Large B-Cell Lymphoma and B-Lineage Acute Lymphoblastic Leukemia.
Guarini A, Radice G, Peragine N, Buracchi C, De Propris MS, Di Rocco A, Di Rocco A, Chiaretti S, Moretti A, Napolitano S, Martelli M, Balduzzi A, Gaipa G, Biondi A, Foà R. Guarini A, et al. Among authors: peragine n. Cancers (Basel). 2023 Apr 22;15(9):2411. doi: 10.3390/cancers15092411. Cancers (Basel). 2023. PMID: 37173879 Free PMC article.
Treatment with ibrutinib does not induce a TP53 clonal evolution in chronic lymphocytic leukemia.
Cafforio L, Raponi S, Cappelli LV, Ilari C, Soscia R, De Propris MS, Mariglia P, Rigolin GM, Bardi A, Peragine N, Piciocchi A, Arena V, Mauro FR, Cuneo A, Guarini A, Foa R, Del Giudice I. Cafforio L, et al. Among authors: peragine n. Haematologica. 2022 Jan 1;107(1):334-337. doi: 10.3324/haematol.2020.263715. Haematologica. 2022. PMID: 34647439 Free PMC article. No abstract available.
TH2/TH1 Shift Under Ibrutinib Treatment in Chronic Lymphocytic Leukemia.
Puzzolo MC, Del Giudice I, Peragine N, Mariglia P, De Propris MS, Cappelli LV, Trentin L, Reda G, Cuneo A, Molica S, Piciocchi A, Arena V, Mauro FR, Guarini A, Foà R. Puzzolo MC, et al. Among authors: peragine n. Front Oncol. 2021 Apr 15;11:637186. doi: 10.3389/fonc.2021.637186. eCollection 2021. Front Oncol. 2021. PMID: 33937038 Free PMC article.
Genetic landscape of ultra-stable chronic lymphocytic leukemia patients.
Raponi S, Del Giudice I, Marinelli M, Wang J, Cafforio L, Ilari C, Piciocchi A, Messina M, Bonina S, Tavolaro S, Bordyuh M, Mariglia P, Peragine N, Mauro FR, Chiaretti S, Molica S, Gentile M, Visentin A, Trentin L, Rigolin GM, Cuneo A, Diop F, Rossi D, Gaidano G, Guarini A, Rabadan R, Foà R. Raponi S, et al. Among authors: peragine n. Ann Oncol. 2018 Apr 1;29(4):966-972. doi: 10.1093/annonc/mdy021. Ann Oncol. 2018. PMID: 29365086 Free PMC article.
47 results